November 04, 2025

Get In Touch

Increased Risk Of Ocular Abnormalities In Extremely Preterm Babies

Study on Extreme Prematurity and Visual Abnormalities

Study on Extreme Prematurity and Visual Abnormalities

In a new study conducted by Saurabh Jain and team, it was found that extreme prematurity is linked to a higher incidence of visual and ocular abnormalities in early adulthood. However, this study further reveals that visual and ocular deficits are somewhat independent of retinopathy of prematurity (ROP) status in the neonatal period for those born Extremely preterm (EP), but that total visual function is similar.

The findings of this study were published in the Journal of American Medical Association.

Preterm babies (those born before 37 weeks of pregnancy) have a greater risk of vision impairment and ocular morbidity than full-term babies. However, for children born EP, who have the highest risk of neonatal retinopathy, the long-term ocular effects in adulthood remain unclear. As a result, the goal of this study was to compare visual function and ocular morbidity in young people born prematurely to controls at full term.

128 individuals aged 19 years (born at 22-25 weeks' gestation) and 65 age-matched controls born at full term were included in this prospective cohort research of a geographically based birth cohort in the UK and Ireland born from March 1 to December 31, 1995. From March 1, 2020, through November 26, 2021, statistical analysis was conducted. As part of a full outcome evaluation, participants had their eyes examined. The Health Utilities Index Mark 3 was used to assess best-corrected visual acuity, refractive status, contrast sensitivity, colour vision, the prevalence of strabismus and nystagmus, and patient-reported visual function.

Key Findings

  • 128 people (256 eyes; 68 female participants [53%]; mean [SD] age, 19.3 [0.5] years) and 65 age-matched controls born at full term were included in the research.
  • When compared to control eyes, the EP group's mean (SD) best-corrected visual acuity was considerably lower.
  • In comparison to the control group, the EP group showed a considerably greater prevalence of strabismus, aberrant ocular motility, and nystagmus.
  • There were no significant variations in refractive error, contrast sensitivity, colour vision, or patient-reported visual function between EP participants and controls.
  • The EP group had 48% of eyes with no ROP, 39% with ROP that did not require neonatal care, and 13% with ROP that required cryotherapy or laser ablation.
  • There was no significant difference in binocular visual function metrics, ocular morbidity prevalence, or patient-reported visual function by neonatal ROP status within the EP group.

In conclusion, these findings shed light on the ocular outcome of EP birth in the general population, and they have implications for the detection and treatment of such deficiencies as they develop over time.

Reference

Jain S, Sim PY, Beckmann J, et al. Functional Ophthalmic Factors Associated With Extreme Prematurity in Young Adults. JAMA Netw Open. 2022;5(1):e2145702. doi:10.1001/jamanetworkopen.2021.45702

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!